1. Home
  2. ELVR vs RNAC Comparison

ELVR vs RNAC Comparison

Compare ELVR & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVR
  • RNAC
  • Stock Information
  • Founded
  • ELVR 2000
  • RNAC 2007
  • Country
  • ELVR Australia
  • RNAC United States
  • Employees
  • ELVR N/A
  • RNAC N/A
  • Industry
  • ELVR Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELVR Industrials
  • RNAC Health Care
  • Exchange
  • ELVR Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • ELVR 254.1M
  • RNAC 276.3M
  • IPO Year
  • ELVR N/A
  • RNAC 2016
  • Fundamental
  • Price
  • ELVR $24.34
  • RNAC $8.20
  • Analyst Decision
  • ELVR
  • RNAC Strong Buy
  • Analyst Count
  • ELVR 0
  • RNAC 4
  • Target Price
  • ELVR N/A
  • RNAC $40.00
  • AVG Volume (30 Days)
  • ELVR 113.3K
  • RNAC 139.5K
  • Earning Date
  • ELVR 10-29-2025
  • RNAC 11-07-2025
  • Dividend Yield
  • ELVR N/A
  • RNAC N/A
  • EPS Growth
  • ELVR N/A
  • RNAC N/A
  • EPS
  • ELVR N/A
  • RNAC N/A
  • Revenue
  • ELVR $146,440,045.00
  • RNAC $1,026,000.00
  • Revenue This Year
  • ELVR $9.75
  • RNAC N/A
  • Revenue Next Year
  • ELVR $8.82
  • RNAC N/A
  • P/E Ratio
  • ELVR N/A
  • RNAC N/A
  • Revenue Growth
  • ELVR 11.20
  • RNAC N/A
  • 52 Week Low
  • ELVR $15.55
  • RNAC $7.75
  • 52 Week High
  • ELVR $33.36
  • RNAC $26.50
  • Technical
  • Relative Strength Index (RSI)
  • ELVR N/A
  • RNAC 34.61
  • Support Level
  • ELVR N/A
  • RNAC $8.75
  • Resistance Level
  • ELVR N/A
  • RNAC $9.49
  • Average True Range (ATR)
  • ELVR 0.00
  • RNAC 0.60
  • MACD
  • ELVR 0.00
  • RNAC -0.10
  • Stochastic Oscillator
  • ELVR 0.00
  • RNAC 8.39

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: